| Dr Johannie Keith Uy, MD | |
|
222 Medical Cir, Morehead, KY 40351-1179 | |
| (606) 783-6471 | |
| Not Available |
| Full Name | Dr Johannie Keith Uy |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 12 Years |
| Location | 222 Medical Cir, Morehead, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154736056 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 308662 (New York) | Primary |
| 207R00000X | Internal Medicine | 50394 (Kentucky) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Penn Highland Dubois | Dubois, PA | Hospital |
| Mount Sinai Hospital | New york, NY | Hospital |
| Penn Highlands Elk | Saint marys, PA | Hospital |
| Penn Highlands Huntingdon | Huntingdon, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Apogee Medical Group Of Pennsylvania Pc | 2668437104 | 134 |
| Icahn School Of Medicine At Mount Sinai | 2264691070 | 2339 |
News Archive
Axios Mobile Assets Corporation today announced it has achieved FDA compliance for its proprietary bio-based trackable pallet and software technology. The solutions meet FDA standards for CFR 21 part 11 compliance based on the pallet's material composition, in accordance to the U.S. Federal Code of Regulation.
For many years, health experts have warned that high levels of bad cholesterol or low-density lipoprotein (LDL) are critical drivers for the development of cardiovascular disease. Now, a new study claims that decades of research have failed to show benefit of targeting the bad cholesterol to reduce the risk of cardiovascular disease.
The first long-term seroprevalence study of residents in Wuhan, China, has found that 6.9% of people in the city had antibodies against COVID-19 in April 2020, and 82% of these people had an asymptomatic infection.
A study published in the current issue of Cell Transplantation, now freely available on-line, has found that when mesenchymal cells derived from skeletal muscle (SM-MSCs) or adipose tissue (ADSCs) were injected into the heart muscle (myocardium) of separate groups of laboratory rats that had suffered a myocardial infarction, rats in both groups experienced significantly improved left ventricle function and smaller infarct size after cell therapy.
Two studies show that modern high-sensitivity troponin I assays can help physicians to rapidly identify patients with a very low likelihood of having non-ST-segment elevation myocardial infarction.
› Verified 6 days ago
| Entity Name | Apogee Medical Group Of Pennsylvania Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568633535 PECOS PAC ID: 2668437104 Enrollment ID: O20041124000275 |
News Archive
Axios Mobile Assets Corporation today announced it has achieved FDA compliance for its proprietary bio-based trackable pallet and software technology. The solutions meet FDA standards for CFR 21 part 11 compliance based on the pallet's material composition, in accordance to the U.S. Federal Code of Regulation.
For many years, health experts have warned that high levels of bad cholesterol or low-density lipoprotein (LDL) are critical drivers for the development of cardiovascular disease. Now, a new study claims that decades of research have failed to show benefit of targeting the bad cholesterol to reduce the risk of cardiovascular disease.
The first long-term seroprevalence study of residents in Wuhan, China, has found that 6.9% of people in the city had antibodies against COVID-19 in April 2020, and 82% of these people had an asymptomatic infection.
A study published in the current issue of Cell Transplantation, now freely available on-line, has found that when mesenchymal cells derived from skeletal muscle (SM-MSCs) or adipose tissue (ADSCs) were injected into the heart muscle (myocardium) of separate groups of laboratory rats that had suffered a myocardial infarction, rats in both groups experienced significantly improved left ventricle function and smaller infarct size after cell therapy.
Two studies show that modern high-sensitivity troponin I assays can help physicians to rapidly identify patients with a very low likelihood of having non-ST-segment elevation myocardial infarction.
› Verified 6 days ago
| Entity Name | Dlp Conemaugh Meyersdale Medical Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932500154 PECOS PAC ID: 0446470041 Enrollment ID: O20150427000756 |
News Archive
Axios Mobile Assets Corporation today announced it has achieved FDA compliance for its proprietary bio-based trackable pallet and software technology. The solutions meet FDA standards for CFR 21 part 11 compliance based on the pallet's material composition, in accordance to the U.S. Federal Code of Regulation.
For many years, health experts have warned that high levels of bad cholesterol or low-density lipoprotein (LDL) are critical drivers for the development of cardiovascular disease. Now, a new study claims that decades of research have failed to show benefit of targeting the bad cholesterol to reduce the risk of cardiovascular disease.
The first long-term seroprevalence study of residents in Wuhan, China, has found that 6.9% of people in the city had antibodies against COVID-19 in April 2020, and 82% of these people had an asymptomatic infection.
A study published in the current issue of Cell Transplantation, now freely available on-line, has found that when mesenchymal cells derived from skeletal muscle (SM-MSCs) or adipose tissue (ADSCs) were injected into the heart muscle (myocardium) of separate groups of laboratory rats that had suffered a myocardial infarction, rats in both groups experienced significantly improved left ventricle function and smaller infarct size after cell therapy.
Two studies show that modern high-sensitivity troponin I assays can help physicians to rapidly identify patients with a very low likelihood of having non-ST-segment elevation myocardial infarction.
› Verified 6 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902347438 PECOS PAC ID: 2860688728 Enrollment ID: O20170524000169 |
News Archive
Axios Mobile Assets Corporation today announced it has achieved FDA compliance for its proprietary bio-based trackable pallet and software technology. The solutions meet FDA standards for CFR 21 part 11 compliance based on the pallet's material composition, in accordance to the U.S. Federal Code of Regulation.
For many years, health experts have warned that high levels of bad cholesterol or low-density lipoprotein (LDL) are critical drivers for the development of cardiovascular disease. Now, a new study claims that decades of research have failed to show benefit of targeting the bad cholesterol to reduce the risk of cardiovascular disease.
The first long-term seroprevalence study of residents in Wuhan, China, has found that 6.9% of people in the city had antibodies against COVID-19 in April 2020, and 82% of these people had an asymptomatic infection.
A study published in the current issue of Cell Transplantation, now freely available on-line, has found that when mesenchymal cells derived from skeletal muscle (SM-MSCs) or adipose tissue (ADSCs) were injected into the heart muscle (myocardium) of separate groups of laboratory rats that had suffered a myocardial infarction, rats in both groups experienced significantly improved left ventricle function and smaller infarct size after cell therapy.
Two studies show that modern high-sensitivity troponin I assays can help physicians to rapidly identify patients with a very low likelihood of having non-ST-segment elevation myocardial infarction.
› Verified 6 days ago
| Entity Name | Dlp Conemaugh Meyersdale Medical Center, Llc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1659376358 PECOS PAC ID: 0446470041 Enrollment ID: O20201102000630 |
News Archive
Axios Mobile Assets Corporation today announced it has achieved FDA compliance for its proprietary bio-based trackable pallet and software technology. The solutions meet FDA standards for CFR 21 part 11 compliance based on the pallet's material composition, in accordance to the U.S. Federal Code of Regulation.
For many years, health experts have warned that high levels of bad cholesterol or low-density lipoprotein (LDL) are critical drivers for the development of cardiovascular disease. Now, a new study claims that decades of research have failed to show benefit of targeting the bad cholesterol to reduce the risk of cardiovascular disease.
The first long-term seroprevalence study of residents in Wuhan, China, has found that 6.9% of people in the city had antibodies against COVID-19 in April 2020, and 82% of these people had an asymptomatic infection.
A study published in the current issue of Cell Transplantation, now freely available on-line, has found that when mesenchymal cells derived from skeletal muscle (SM-MSCs) or adipose tissue (ADSCs) were injected into the heart muscle (myocardium) of separate groups of laboratory rats that had suffered a myocardial infarction, rats in both groups experienced significantly improved left ventricle function and smaller infarct size after cell therapy.
Two studies show that modern high-sensitivity troponin I assays can help physicians to rapidly identify patients with a very low likelihood of having non-ST-segment elevation myocardial infarction.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Johannie Keith Uy, MD 2510 30th Ave, Astoria, NY 11102-2448 Ph: (718) 932-1000 | Dr Johannie Keith Uy, MD 222 Medical Cir, Morehead, KY 40351-1179 Ph: (606) 783-6471 |
News Archive
Axios Mobile Assets Corporation today announced it has achieved FDA compliance for its proprietary bio-based trackable pallet and software technology. The solutions meet FDA standards for CFR 21 part 11 compliance based on the pallet's material composition, in accordance to the U.S. Federal Code of Regulation.
For many years, health experts have warned that high levels of bad cholesterol or low-density lipoprotein (LDL) are critical drivers for the development of cardiovascular disease. Now, a new study claims that decades of research have failed to show benefit of targeting the bad cholesterol to reduce the risk of cardiovascular disease.
The first long-term seroprevalence study of residents in Wuhan, China, has found that 6.9% of people in the city had antibodies against COVID-19 in April 2020, and 82% of these people had an asymptomatic infection.
A study published in the current issue of Cell Transplantation, now freely available on-line, has found that when mesenchymal cells derived from skeletal muscle (SM-MSCs) or adipose tissue (ADSCs) were injected into the heart muscle (myocardium) of separate groups of laboratory rats that had suffered a myocardial infarction, rats in both groups experienced significantly improved left ventricle function and smaller infarct size after cell therapy.
Two studies show that modern high-sensitivity troponin I assays can help physicians to rapidly identify patients with a very low likelihood of having non-ST-segment elevation myocardial infarction.
› Verified 6 days ago
Albert J Smith Jr., MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 606-783-6500 | |
Indu Shivaram, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 245 Flemingsburg Rd, Morehead, KY 40351 Phone: 606-780-5500 Fax: 606-780-5512 | |
Ravneet Thind, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 245 Flemingsburg Rd, Morehead, KY 40351 Phone: 606-780-5500 | |
Dr. Mansha U Kahloon, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 245 Flemingsburg Rd, Morehead, KY 40351 Phone: 606-780-5500 Fax: 606-780-5512 | |
Shea Poynter Lambirth, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 606-783-6500 | |
Christie Dawn Conn, PA-C Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2300 Ky 801 North, Morehead, KY 40351 Phone: 606-548-5550 Fax: 833-471-4492 |